Charmaine England - Jan 1, 2024 Form 3 Insider Report for Kenvue Inc. (KVUE)

Role
Chief Growth Officer
Signature
/s/ Alla Berenshteyn, as attorney-in-fact
Stock symbol
KVUE
Transactions as of
Jan 1, 2024
Transactions value $
$0
Form type
3
Date filed
1/5/2024, 06:33 PM
Next filing
Feb 12, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding KVUE Restricted Stock Units Jan 1, 2024 Common Stock 3.87K Direct F1, F2
holding KVUE Restricted Stock Units Jan 1, 2024 Common Stock 3.73K Direct F1, F3
holding KVUE Restricted Stock Units Jan 1, 2024 Common Stock 4.69K Direct F1, F4
holding KVUE Restricted Stock Units Jan 1, 2024 Common Stock 9.98K Direct F5, F6
holding KVUE Restricted Stock Units Jan 1, 2024 Common Stock 9.31K Direct F3, F5
holding KVUE Restricted Stock Units Jan 1, 2024 Common Stock 15K Direct F4, F5
holding KVUE Stock Options Jan 1, 2024 Common Stock 20.6K $20.32 Direct F7
holding KVUE Stock Options Jan 1, 2024 Common Stock 32.1K $21.97 Direct F2, F8
holding KVUE Stock Options Jan 1, 2024 Common Stock 36.8K $22.40 Direct F3, F8
holding KVUE Stock Options Jan 1, 2024 Common Stock 51.5K $22.23 Direct F4, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These restricted share units ("RSUs") were originally granted by Johnson & Johnson and, in connection with the Issuer's separation from Johnson & Johnson on August 23, 20223 (the "Separation") and pursuant to the terms of the Employee Matters Agreement, dated as of May 3, 2023 between Johnson & Johnson and the Issuer (the "Employee Matters Agreement"), were converted into RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value.
F2 This award vests in three equal installments on 02/13/2024, 02/13/2025, and 02/13/2026, subject to the reporting person's continued service through such vesting date.
F3 This award will vest in full on 02/14/2025, subject to the reporting person's continued service through such vesting date.
F4 This award will vest in full on 02/08/2024, subject to the reporting person's continued service through such vesting date.
F5 These RSUs were originally granted by Johnson & Johnson as performance share units and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into time-based RSUs with respect to Issuer common stock with adjustments made to the number of shares subject to the award in order to preserve the award's value and with performance criteria deemed satisfied at the target level, unless two years have been completed in the performance period, in which case performance was deemed satisfied at the level of performance for such years.
F6 This award will vest in full on 02/13/2026, subject to the reporting person's continued service through such vesting date.
F7 This award will vest in full on 10/02/2026, subject to the reporting person's continued service through such vesting date.
F8 These stock options were originally granted by Johnson & Johnson and, in connection with the Separation and pursuant to the terms of the Employee Matters Agreement, were converted into options with respect to Issuer common stock with adjustments made to the number of shares subject to the award and its exercise price in order to preserve the award's value.

Remarks:

See Exhibit 24 - Power of Attorney